Scleroderma Literature Highlights – October 2025

Keywords:

Efficacy, Outcomes, Phase 2, Safety, Skin, Safety, Lung/ILD, Nailfold capillaroscopy, Systemic sclerosis, Progression, Combination, Interstitial lung disease, mRSS, Mycophenolate mofetil, Rituximab, Systemic sclerosis.

LinkedIn